What proportion of patients with heart failure and preserved ejection fraction are eligible for empagliflozin?
J Cardiovasc Med (Hagerstown). 2022 Aug 1;23(8):567-569. doi: 10.2459/JCM.0000000000001331.
J Cardiovasc Med (Hagerstown). 2022.
PMID: 35901508
No abstract available.